Q32 Bio Inc (QTTB)

Q32 Bio Inc (QTTB) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $232M; returns 1 day -1.7%, 1 week +15.0%, 1 year +208.9%.

Q32 Bio Inc. is a clinical-stage biotechnology company focused on developing biologics designed to restore immune balance by targeting both the innate and adaptive immune systems. The company's primary revenue driver currently stems from strategic licensing agreements and collaborations rather than commercial product sales.

Groups QTTB belongs to

• Biotechnology
• Clinical Stage
• Clinical Stage Biotech
• Healthcare
• Biopharmaceutical
• Biologics
• Autoimmune Diseases
• Chronic Inflammatory Diseases
• Antibody Therapeutics
• Monoclonal Antibodies
• Dermatology
• Alopecia Areata

QTTB financial model: income statement, cash flow and balance sheet